Public health officials say the United States needs a plan and infrastructure to avoid the fragmented response to a new disease that marked its response to the COVID pandemic.
“We don’t have a systemic approach to medical product testing,” said Dr. Janet Woodcock, principal deputy commissioner for the U.S. Food and Drug Administration (FDA).